Physician
Moore Rucker, Susan
Moore Rucker, Susan was paid $151K by Medicaid between Apr 2018 and Dec 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoMOORE RUCKER, SUSAN
ATHENS, TN 37303
ATHENS, TN 37303
33aNPI1104967306assigned 02/09/2007
33bProvider typePediatrics Physician
28Total paid$151K
24GClaims3,088
24DCodes billed12
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#164 of 333
Median peer was paid$139K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 215 | $5K | |
| 2019 | 290 | $9K | |
| 2020 | 554 | $28K | |
| 2021 | 743 | $44K | |
| 2022 | 715 | $39K | |
| 2023 | 394 | $18K | |
| 2024incomplete | 177 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 1,709 | 1,512 | $76K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 760 | 687 | $60K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.2% | 171 | 161 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 81 | 69 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 58 | 57 | $881.95 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 15 | 12 | $864.72 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 44 | 37 | $797.54 |
| 92551 | <1% | 91 | 83 | $700.92 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 17 | 16 | $679.04 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 60 | 26 | $383.39 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 21 | 15 | $277.45 |
| 96127 | <1% | 61 | 53 | $211.94 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.